CareDx (CDNA) director receives 9,795-share RSU grant, holdings reach 58,943

Rhea-AI Filing Summary

COURNOYER CHRISTINE reported acquisition or exercise transactions in this Form 4 filing.

CareDx, Inc. director Christine Cournoyer received a grant of 9,795 shares of common stock in the form of restricted stock units. The RSUs vest 100% on the earlier of one year after the grant date or immediately before the first annual meeting after the grant, subject to continued service. Following this grant, she directly holds 58,943 shares.

Insider Trade Summary 10b5-1

1 transaction reported

Mixed 1 txn

Insider COURNOYER CHRISTINE

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,795	$0.00	--

Holdings After Transaction: Common Stock — 58,943 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 9,795 shares Grant price per share: $0.00 per share Post-transaction holdings: 58,943 shares +1 more

4 metrics

RSU grant size 9,795 shares Restricted stock units awarded to director on grant date

Grant price per share $0.00 per share RSU award granted at no purchase price

Post-transaction holdings 58,943 shares Total CareDx common shares directly held after grant

Vesting schedule 100% cliff vest Earlier of one year after grant or before first annual meeting after grant

Key Terms

restricted stock units, RSUs, Annual Meeting

3 terms

restricted stock units financial

"The reported securities are represented by restricted stock units ("RSUs")"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"The reported securities are represented by restricted stock units ("RSUs")"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Annual Meeting financial

"on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COURNOYER CHRISTINE

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BOULEVARD, 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		A		9,795(1)	A	$0	58,943	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CareDx (CDNA) report for Christine Cournoyer?

CareDx reported that director Christine Cournoyer received 9,795 shares of common stock through a restricted stock unit grant. These shares were awarded at no purchase price and increased her direct holdings to 58,943 shares after the transaction.

How many CareDx (CDNA) shares does Christine Cournoyer hold after this Form 4?

After the reported RSU grant, Christine Cournoyer directly holds 58,943 shares of CareDx common stock. This total reflects the addition of 9,795 restricted stock units granted as a stock-based compensation award to her as a director.

What are the vesting terms of the RSUs granted to the CareDx (CDNA) director?

The restricted stock units granted to the CareDx director vest 100% on the earlier of one year from the grant date or the day immediately before the first annual meeting after the grant. Vesting requires the director’s continuous service through the applicable vesting date.

Was the CareDx (CDNA) Form 4 transaction a market purchase or sale?

The Form 4 transaction was not a market purchase or sale. It was a grant of 9,795 restricted stock units awarded at a price of $0.00 per share as stock-based compensation to director Christine Cournoyer.

Does the CareDx (CDNA) Form 4 indicate any derivative security activity?

The Form 4 does not report any derivative security exercises or conversions. It only shows a non-derivative acquisition of 9,795 shares of common stock through a restricted stock unit grant, with no remaining derivative positions listed in the derivative summary.